Salary range is $64,957 - $102,166 dependent on experience and accomplishments.
Preferred Education:
Masters
The National Institutes of Health (NIH) invites candidates with a GMP cell processing background to apply for multiple Biologists (Manufacturing) positions in the Cell Therapy Manufacturing Section of the Center for Cellular Engineering at the NIH Clinical Center, Bethesda, MD. The NIH Clinical Center is the largest hospital in the world, totally dedicated to translational clinical research. The hospital maintains a 200-bed capacity that supports the intramural research programs of Institutes and Centers across the NIH. The hospital supports an extensive range of acute care patients who are research participants with long-standing relationships with their care team.
The Center for Cellular Engineering (CCE), which is part of the Department of Transfusion Medicine (DTM), serves as a trans-NIH core facility for the manufacture of novel and standard transplant cellular therapy (CT) products in support of early-phase and first-in-human clinical trials and research trials. The clinical products include those used for hematopoietic progenitor cell (HPC) transplantation and immunotherapy, including genetically modified cells such as CAR-T cells, TCRs, iPSCs, HPCs, etc. The CCE contributes to leveraging collaborative relationships with investigators to move innovative cellular therapies quickly and efficiently through the product life cycle. The purpose of this position is to manufacture cell and gene therapy products for clinical and research protocols in accordance with regulatory and accrediting agency requirements, including the AABB Standards for Cellular Therapy Product Service.
We seek multiple biologists with relevant experience in clinical labs or GMP cell processing and cell culture. The ideal candidate should possess a bachelor's and master's degree or a medical technology degree in a relevant field. Responsibilities will include, but are not limited to, performing cell processing and laboratory testing such as elutriation, density gradient, and magnetic bead cell separations, ex vivo cell culture, gene incorporation using viral vectors following SOPs in a clean room environment; operation of instrumentation such as cell washers and cell separators and analyzers as needed; identifies and communicates problems and performs troubleshooting by working with Team leads and supervisors, completes manufacturing documentation and make relevant corrections as needed; assists with other tasks assigned such as investigations and validations.
HHS and NIH are Equal Opportunity Employers. Selection for this position will be based solely on merit, without discrimination for non-merit reasons such as race, color, religion, sex, national origin, politics, marital status, sexual orientation, physical or mental handicap, age, or membership or non-membership in an employee organization. You must be a U.S. Citizen or U.S. National. All selected candidates are subject to a background investigation and must pass a medical screening.
GS 9/11 Biologist (Manufacturing): Salary range is $64,957 - $102,166 dependent on experience and accomplishments. A complete Civil Service package of benefits (including retirement, health, life insurance, Thrift Savings Plan, etc.) is available. Applications must be submitted via the www.usajobs.gov website, job announcement NIH-CC-DE-24-12128408 and NIH-CC-MP-24-12128448, that will be open from October 18, 2023, to midnight on October 27, 2023.
GS 12 Biologist (Manufacturing): Salary range is $94,199 - $122,459 dependent on experience and accomplishments. A complete Civil Service package of benefits (including retirement, health, life insurance, Thrift Savings Plan, etc.) is available. Applications must be submitted via the www.usajobs.gov website, job announcement NIH-CC-DE-24-12131753 and NIH-CC-MP-24-12131771, that will be open from October 18, 2023, to midnight on October 27, 2023.
About National Institute of Health Clinical Center
The Center for Cellular Engineering (CCE), which is part of the Department of Transfusion Medicine (DTM), serves as a trans-NIH core facility for the manufacture of novel and standard transplant cellular therapy (CT) products in support of early-phase and first-in-human clinical trials and research trials. The clinical products include those used for hematopoietic progenitor cell (HPC) transplantation and immunotherapy, including genetically modified cells such as CAR-T cells, TCRs, iPSCs, HPCs, etc. The CCE contributes to leveraging collaborative relationships with investigators to move innovative cellular therapies quickly and efficiently through the product life cycle.